medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 5

<< Back Next >>

Rev Mex Pediatr 2019; 86 (5)

Neonatal infectious endocarditis: diagnosis and treatment

Cullen‑Benítez PJ, González‑Morán RJ, Hidalgo‑Vázquez MM, López‑Enríquez CC, Martínez‑Hernández A, Barrón‑San Pedro R, Iglesias‑Leboreiro J
Full text How to cite this article 10.35366/SP195H

DOI

DOI: 10.35366/SP195H
URL: https://dx.doi.org/10.35366/SP195H

Language: Spanish
References: 32
Page: 202-209
PDF size: 315.61 Kb.


Key words:

Infectious endocarditis, newborn, congenital heart disease, central catheter, endocardial thrombus, Duke criteria.

ABSTRACT

Infectious endocarditis is a valvular or mural endocardial inflammation caused by microorganisms. Subacute presentation is the most frequent form in newborns. Risk factors associated to endocarditis are post-cardiac surgery patients, congenital heart disease, and use of central catheters for prolonged periods of time; the former is the most common in neonates. Annual incidence of endcarditis is 0.05 to 0.12 cases per 1,000 hospitalized children and 7% in neonates. Duke and Li are the most widely accepted criteria for diagnosis, where clinical evidence, imaging studies and microbiology are mandatory. Staphylococcus followed by Streptococcus are the most frequent causal germs, followed by Gram-negative bacilli, fungus and Enterococcus; polymicrobial germs are the less frequent. Combination of antimicrobial treatment is the cornerstone, where at least one needs to be bactericidal. Antimicrobial combination should be based on in vitro susceptibility and local known epidemiology. Central devices ought to be removed, and blood cultures must be obtained daily until they are become negative. Surgical treatment is reserved for those patients with life threatening complications.


REFERENCES

  1. Welsch U. Aparato cardiovascular. En: Welsch U. Histología. 2a edición. Madrid, España: Editorial Panamericana; 2010. pp. 235-258.

  2. Aleixandre de Artiñano MA, Ortega-Mateo AI. Importancia fisiológica del endotelio. En: Aleixandre de Artiñano MA, Ortega-Mateo AI. Función y disfunción endotelial. Madrid, España: Editorial Complutense; 2000. pp. 1-15.

  3. Hoyer A, Silberbach M. Infective endocarditis. Pediatr Rev. 2005; 26 (11): 394-400.

  4. Olivera AC, Libian LS. Endocarditis infecciosa. Tratamiento y profilaxis. En: Zabala AJI. Protocolos diagnósticos y terapéuticos en cardiología pediátrica. 2010. Sociedad Española de Cardiología Pediátrica y Cardiopatías Congénitas. Disponible en: www.secardioped.org/readcontents.php?file=webstructure/protocolos_2010.pdf

  5. Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB et al. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association. Circulation. 2015; 132 (15): 1487-1515.

  6. Pasquali SK, He X, Mohamad Z, McCrindle BW, Newburger JW, Li JS et al. Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. Am Heart J. 2012; 143: 894-899.

  7. Day MD, Gauvreau K, Schulman S, Newburger JW. Characteristics of children hospitalized with infective endocarditis. Circulation. 2009; 119 (6): 865-870.

  8. Opie FG, Fraser SH, Drew JH, Drew S. Bacterial endocarditis in neonatal intensive care. J Pediatr Child Health. 1999; 35: 545-548.

  9. Knirsch W, Nadal D. Infective endocarditis in congenital heart disease. Eur J Pediatr. 2011; 170 (9): 1111-1127.

  10. Taib R. Infective endocarditis in children. Southeast Asian J Trop Med Public Health. 2014; 45 Suppl 1: 79-85.

  11. Mecrow IK, Ladusans EJ. Infective endocarditis in newborn infants with structurally normal hearts. Acta Paediatr. 1994; 83 (1): 35-39.

  12. Walsh MJ, Avinash KS. Infective endocarditis. En: Ungerleider RM, Meliones JN, McMillan KN, Cooper DS, Jacobs JP. Critical heart disease in infants and children. 3rd ed. Philadelphia PA: Elsevier; 2019. pp. 823-835.

  13. Fye WB, Fernel JF. Profiles in cardiology. Clin Cardiol. 1997; 20: 1037-1038.

  14. Carceller A. Endocarditis infecciosa. An Pediatr (Barc). 2005; 63 (5): 383-389.

  15. Von Reyn CF, Levy B, Arbeit RD, Friedland G, Crumpacker C. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med. 1981; 94: 505-518.

  16. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994; 96 (3): 200-209.

  17. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000; 3 (4): 633-638.

  18. Hoen B, Duval X. Infective endocarditis. N Eng J Med. 2013; 368: 1425-1433.

  19. Meyer Z, Fischer M, Koerfer J, Laser KT, Kececioglu D, Burchert W et al. The role of FDG-PET-CT in pediatric cardiac patients and patients with congenital heart defects. Int J Cardiol. 2016; 220: 656-660.

  20. Dixon G, Christov G. Infective endocarditis in children. Curr Opin Infent Dis. 2017; 30: 257-267.

  21. Stockheim JA. Cardiac infections. En: Rudolph CD. Rudolpfh’s pediatrics. 22nd edition. New York: McGraw Hill; 2011.

  22. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Eng J Med. 2001; 345 (18): 1318-1330.

  23. Ganesan V, Ponnusamy SS, Sundaramurthy R. Fungal endocarditis in paediatrics: a review of 192 cases (1971-2016). Cardiol Young. 2017; 27 (8): 1481-1487.

  24. Andreas HG, Emmanuel R, Thomas JW. Chapter 22, Section 3: Fungal infections in pediatric patients. En: Clinical mycology. Thu Nguyen/Sue Hodgson, 481-500, Elsevier Health Sciences, UK; 2009.

  25. Santoro J, Ingerman M. Response to therapy: relapses and reinfections. En: Kaye D, ed. Infective endocarditis. 2nd ed. New York, NY: Raven Press; 1992. pp. 423-434.

  26. Habib G, Lancellotti P, Antunes MJ, Bongiomi MG, Casalta JP, Del Zotti F et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015; 36: 3075-3128.

  27. Nelson MU, Gallagher PG. Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit. Semin Perinatol. 2012; 36 (6): 424-430.

  28. Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL. A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clin Infect Dis. 2018; 67 (2): 303-309.

  29. Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Clin Infect Dis. 2013; 56 (9): 1261-1268.

  30. Pana ZD, Dotis J, Iosifidis E, Roilides E. Fungal endocarditis in neonates: a review of seventy-one cases (1971-2013). Pediatr Infect Dis J. 2015; 34 (8): 803-808.

  31. Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST et al. Unique features of infective endocarditis in childhood. Pediatrics. 2002; 109 (5): 931-943.

  32. Ozdemir AA. Recombinant tissue plasminogen activator treatment for intracardiac vegetation in a very low birth weight infant. Arch Argent Pediatr. 2017; 115 (5): e307-e310.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2019;86